The Gross Margin of Immune Pharmaceuticals Inc (IMNPQ) is 26.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2017-12-31 | 26.60% |
2016-12-31 | 94.87% |
2015-12-31 | 26.60% |
2014-12-31 | -1.01% |
2013-12-31 | 100.00% |